LOWVELO Funds in Action
News
Ehlers-Danlos syndrome
In the world of complex diseases, few conditions are as misunderstood – and as life-altering – as Ehlers- Danlos syndrome (EDS).
Evaluating Novel Therapy
Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.
All News Articles
All
Influence
Showing 1 – 8 (of 8)
An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.
Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.
The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.
Symposium will bring together researchers and patient advocates to inform policy and chart the way forward for patients with rare diseases.
Carol Feghali-Bostwick, internationally recognized translational researcher, has been named a fellow of the National Academy of Inventors.
MUSC President David Cole names winners of 2023 Values in Action Awards.
Graduate student Sarah Dooley shows young women that brilliant is beautiful by becoming a princess in the lab.
An increase in cervical cancer deaths in Appalachian Kentucky could point to hidden issues in other regions of persistent poverty.
Showing 1 – 8 (of 8)